Prevalence of Vitamin D Deficiency Among Newborns

R Kishore Kumar1, Hari Das2, S V Girish3

  • 1Department of Neonatology, Cloudnine Hospital, Jayanagar, Bengluru, Karnataka. India. drkishore@cloudninecare.com.

Indian Pediatrics
|March 22, 2020
PubMed

Insights

Most newborns (92.1%) have vitamin D deficiency at birth. Early screening and vitamin D supplementation are crucial for infant health.

Area of Science:

  • Neonatology
  • Pediatric Nutrition
  • Endocrinology

Background:

  • Vitamin D deficiency (VDD) is a global health concern.
  • Neonatal vitamin D status is critical for long-term health outcomes.
  • Limited data exists on the prevalence of VDD in healthy newborns at birth.

Purpose of the Study:

  • To determine the prevalence of vitamin D deficiency in healthy newborns at birth.
  • To establish the need for early screening and intervention strategies.

Main Methods:

  • Prospective observational study.
  • Inclusion of 825 healthy newborns at our institution.
  • Assessment of vitamin D levels at birth.

Main Results:

  • A high prevalence of vitamin D deficiency was observed, with 760 (92.1%) newborns affected.
  • Vitamin D deficiency was prevalent even in healthy newborns.

Conclusions:

  • Vitamin D deficiency is highly prevalent in newborns at birth.
  • Routine screening for vitamin D deficiency in newborns is recommended.
  • Early vitamin D supplementation should be considered for infants.

Related Concept Videos

Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
7.3K
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.2K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
183
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
4.8K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
180
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
197